Pillsbury advised Acer Therapeutics on the deal.Acer Therapeutics, a leading pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
